SEMA3F and hepatocellular carcinoma: A number of studies reported that SEMA3F, UCK2, NOL10, RAP2A, ZIC2 and SAC3D1 are associated with prognosis and tumour immune infiltration in hepatocellular carcinomas (21–25).